Annual report pursuant to Section 13 and 15(d)

Condensed Consolidating Financial Information (Details 1)

v2.4.0.8
Condensed Consolidating Financial Information (Details 1) (USD $)
In Millions, unless otherwise specified
3 Months Ended 12 Months Ended
Feb. 28, 2014
Nov. 30, 2013
Aug. 31, 2013
May 31, 2013
Feb. 28, 2013
Nov. 30, 2012
Aug. 31, 2012
May 31, 2012
Feb. 28, 2014
Feb. 28, 2013
Feb. 29, 2012
Condensed Consolidating Statement of Comprehensive Income                      
Sales                 $ 5,411.0 $ 3,171.4 $ 2,979.1
Less – excise taxes                 (543.3) (375.3) (324.8)
Net sales 1,291.2 1,443.3 1,459.8 673.4 695.9 766.9 698.5 634.8 4,867.7 2,796.1 2,654.3
Cost of product sold                 (2,876.0) (1,687.8) (1,592.2)
Gross profit 548.9 609.7 577.0 256.1 261.8 310.8 285.1 250.6 1,991.7 1,108.3 1,062.1
Selling, general and administrative expenses                 (895.1) (585.4) (537.5)
Impairment of goodwill and intangible assets                 (300.9) 0 (38.1)
Gain on remeasurement to fair value of equity method investment                 1,642.0 0 0
Operating income                 2,437.7 522.9 486.5
Equity in earnings of equity method investees and subsidiaries                 87.8 233.1 228.5
Interest income                 7.7 6.8 6.6
Intercompany interest income                 0 0 0
Interest expense                 (330.9) (233.9) (187.6)
Intercompany interest expense                 0 0 0
Loss on write-off of financing costs                 0 (12.5) 0
Income before income taxes                 2,202.3 516.4 534.0
Benefit from (provision for) income taxes                 (259.2) (128.6) (89.0)
NET INCOME 157.2 211.0 1,522.0 52.9 81.7 109.5 124.6 72.0 1,943.1 387.8 445.0
Comprehensive income                 1,897.0 346.2 429.9
Parent Company [Member]
                     
Condensed Consolidating Statement of Comprehensive Income                      
Sales                 2,351.8 2,065.4 1,319.1
Less – excise taxes                 (317.3) (213.0) (169.2)
Net sales                 2,034.5 1,852.4 1,149.9
Cost of product sold                 (1,730.3) (1,537.2) (864.3)
Gross profit                 304.2 315.2 285.6
Selling, general and administrative expenses                 (395.4) (344.1) (237.3)
Impairment of goodwill and intangible assets                 0   0
Gain on remeasurement to fair value of equity method investment                 0    
Operating income                 (91.2) (28.9) 48.3
Equity in earnings of equity method investees and subsidiaries                 2,219.2 622.2 590.5
Interest income                 0.1 0.6 0.2
Intercompany interest income                 152.4 79.0 78.2
Interest expense                 (283.2) (230.1) (180.6)
Intercompany interest expense                 (168.1) (193.2) (154.3)
Loss on write-off of financing costs                   (12.5)  
Income before income taxes                 1,829.2 237.1 382.3
Benefit from (provision for) income taxes                 113.9 150.7 62.7
NET INCOME                 1,943.1 387.8 445.0
Comprehensive income                 1,897.0 346.2 429.9
Subsidiary Guarantors [Member]
                     
Condensed Consolidating Statement of Comprehensive Income                      
Sales                 3,868.3 1,758.6 1,721.4
Less – excise taxes                 (155.9) (95.9) (93.5)
Net sales                 3,712.4 1,662.7 1,627.9
Cost of product sold                 (2,661.6) (1,156.6) (1,063.2)
Gross profit                 1,050.8 506.1 564.7
Selling, general and administrative expenses                 (361.7) (101.4) (187.8)
Impairment of goodwill and intangible assets                 0   0
Gain on remeasurement to fair value of equity method investment                 1,642.0    
Operating income                 2,331.1 404.7 376.9
Equity in earnings of equity method investees and subsidiaries                 92.7 232.9 240.3
Interest income                 0 0 0
Intercompany interest income                 168.5 193.2 125.5
Interest expense                 (2.5) (1.4) (4.6)
Intercompany interest expense                 (153.6) (80.2) (50.5)
Loss on write-off of financing costs                   0  
Income before income taxes                 2,436.2 749.2 687.6
Benefit from (provision for) income taxes                 (292.5) (274.7) (158.5)
NET INCOME                 2,143.7 474.5 529.1
Comprehensive income                 2,167.7 439.5 502.4
Subsidiary Nonguarantors [Member]
                     
Condensed Consolidating Statement of Comprehensive Income                      
Sales                 2,093.9 827.8 712.0
Less – excise taxes                 (70.1) (66.4) (62.1)
Net sales                 2,023.8 761.4 649.9
Cost of product sold                 (1,312.1) (460.8) (389.6)
Gross profit                 711.7 300.6 260.3
Selling, general and administrative expenses                 (155.0) (154.3) (161.0)
Impairment of goodwill and intangible assets                 (300.9)   (38.1)
Gain on remeasurement to fair value of equity method investment                 0    
Operating income                 255.8 146.3 61.2
Equity in earnings of equity method investees and subsidiaries                 0.6 0.5 4.3
Interest income                 7.6 6.2 6.4
Intercompany interest income                 1.5 1.5 1.4
Interest expense                 (45.2) (2.4) (2.4)
Intercompany interest expense                 (0.7) (0.3) (0.3)
Loss on write-off of financing costs                   0  
Income before income taxes                 219.6 151.8 70.6
Benefit from (provision for) income taxes                 (100.1) (4.5) 6.5
NET INCOME                 119.5 147.3 77.1
Comprehensive income                 64.0 103.5 85.5
Eliminations [Member]
                     
Condensed Consolidating Statement of Comprehensive Income                      
Sales                 (2,903.0) (1,480.4) (773.4)
Less – excise taxes                 0 0 0
Net sales                 (2,903.0) (1,480.4) (773.4)
Cost of product sold                 2,828.0 1,466.8 724.9
Gross profit                 (75.0) (13.6) (48.5)
Selling, general and administrative expenses                 17.0 14.4 48.6
Impairment of goodwill and intangible assets                 0   0
Gain on remeasurement to fair value of equity method investment                 0    
Operating income                 (58.0) 0.8 0.1
Equity in earnings of equity method investees and subsidiaries                 (2,224.7) (622.5) (606.6)
Interest income                 0 0 0
Intercompany interest income                 (322.4) (273.7) (205.1)
Interest expense                 0 0 0
Intercompany interest expense                 322.4 273.7 205.1
Loss on write-off of financing costs                   0  
Income before income taxes                 (2,282.7) (621.7) (606.5)
Benefit from (provision for) income taxes                 19.5 (0.1) 0.3
NET INCOME                 (2,263.2) (621.8) (606.2)
Comprehensive income                 $ (2,231.7) $ (543.0) $ (587.9)